Myocardial protection against reperfusion injury: The cGMP pathway

Thrombosis and Haemostasis

Volumn 101, Issue 4, 2009, Pages 635-642

  Garcia Dorado, David ^a   Agulló, Luis ^a   Sartorio, Carmem Lluisa ^a   Ruiz Meana, Marisol ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute myocardial infarction; Ischaemic heart disease; Platelet physiology

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM; CYCLIC GMP; URODILATIN;

ACUTE HEART INFARCTION; CELL DEATH; CONFERENCE PAPER; CORONARY ARTERY; CYTOSKELETON; ENDOTHELIUM CELL; GAP JUNCTION; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CARDIOVASCULAR AGENTS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; SECOND MESSENGER SYSTEMS; TIME FACTORS;

EID: 64849095173     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0764     Document Type: Conference Paper

References (94)

1. Garcia-Dorado D, Théroux P, Duran JM, et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992; 85: 1160-1174.
2. Meng H P, Lonsberry BB, Pierce GN. Influence of perfusate pH on the postischaemic recovery of cardiac contractile function: involvement of sodium-hydrogen exchange. J Pharmacol Exp Ther 1991; 258: 772-777.
3. Schäfer C, Ladilov Y, Inserte J, et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001; 51: 241-250.
4. Goldstein I, Lue T F, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404.
5. Cusson JR, Hamet P, Gutkowska J, et al. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. J Hypertens 1987; 5: 435-443.
6. Vander Heide RS, Angelo J P, Altschuld RA, et al. Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes. Am J Pathol 1986; 125: 55-68.
7. Piper HM, García-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998; 38: 291-300.
8. Barrabés JA, Garcia-Dorado D, Ruiz-Meana M, et al. Myocardial segment shrinkage during coronary reperfusion in situ. Relation to hypercontracture and myocardial necrosis. Pflugers Arch 1996; 431: 519-526.
9. Inserte J, Garcia-Dorado D, Ruiz-Meana M, et al. Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res 2002; 55: 739-748.
10. Siegmund B, Schlack W, Ladilov Y V, et al. Halothane protects cardiomyocytes against reoxygenationinduced hypercontracture. Circulation 1997; 96: 4372-4379.
11. Abdallah Y, Gkatzoflia A, Pieper H, et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 2005; 66: 123-131.
12. Ruiz-Meana M, García-Dorado D, González MA, et al. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition. Cardiovasc Res 1995; 30: 64-69.
13. Inserte J, Garcia-Dorado D, Hernando V, et al. Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischaemia. Circ Res 2005; 97: 465-473.
14. Inserte J, Garcia-Dorado D, Hernando V, et al. Ischaemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion. Cardiovasc Res 2006; 70: 364-373.
15. Inserte J, Garcia-Dorado D, Ruiz-Meana M, et al. Ischaemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res 2004; 64: 105-114.
16. Garcia-Dorado D, Théroux P, Munoz R, et al. Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size. Am J Physiol 1992; 262: H17-22.
17. Ruiz-Meana M, Garcia-Dorado D, Hofstaetter B, et al. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ Res 1999; 85: 280-287.
18. Garcia-Dorado D, Inserte J, Ruiz-Meana M, et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96: 3579-3586.
19. Rodriguez-Sinovas A, García-Dorado D, Ruiz- Meana M, et al. Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium. J Physiol 2004; 559: 245-257.
20. Duchen MR, McGuinness O, Brown LA, et al. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 1993; 27: 1790-1794.
21. Griffiths EJ, Halestrap A P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995; 307: 93-98.
22. Di Lisa F, Menabo R, Canton M, et al. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischaemic reperfusion of the heart. J Biol Chem 2001; 276: 2571-2575.
23. Halestrap A P, Brennerb C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003; 10: 1507-1525.
24. Honda HM, Korge P, Weiss JN. Mitochondria and ischaemia/reperfusion injury. Ann N Y Acad Sci 2005; 1047: 248-258.
25. Ruiz-Meana M, Abellán A, Miró-Casas E, et al. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol 2007; 102: 542-552.
26. Barrabés JA, Garcia-Dorado D, Oliveras J, et al. Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin. Pflugers Arch 1996; 432: 663-670.
27. Barrabés JA, Garcia-Dorado D, Soriano B, et al. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization. Cardiovasc Res 2000; 47: 265-273.
28. Barrabés JA, Garcia-Dorado D, Mirabet M, et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischaemia. J Am Coll Cardiol 2005; 45: 293-299.
29. Mirabet M, Garcia-Dorado D, Ruiz-Meana M, et al. Thrombin increases cardiomyocyte acute cell death after ischaemia and reperfusion. J Mol Cell Cardiol 2005; 39: 277-283.
30. Barrabés JA, Mirabet M, Agulló L, et al. Platelet deposition in remote cardiac regions after coronary occlusion. Eur J Clin Invest 2007; 37: 939-946.
31. Hess ML, Rowe GT, Caplan M, et al. Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-induced myocardial dysfunction. Limitation of infarct size with neutrophil inhibition and depletion. Adv Myocardiol 1985; 5: 159-175.
32. Tofukuji M, Metais C, Collard CD, et al. Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig. Ann Thorac Surg 1999; 67: 112-119.
33. Ceriana P. Effect of myocardial ischaemia-reperfusion on granulocyte elastase release. Anaesth Intensive Care 1992; 20: 187-190.
34. Hempel AM, Friedrich M, Schlüter KD, et al. ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. Am J Physiol 1997; 273: 244-249.
35. Agulló L, García-Dorado D, Inserte J, et al. L-arginine limits myocardial cell death secondary to hypoxiareoxygenation by a cGMP-dependent mechanism. Am J Physiol 1999; 276: H1574-1580.
36. Inserte J, Garcia-Dorado D, Agulló L, et al. Urodilatin limits acute reperfusion injury in the isolated rat heart. Cardiovasc Res 2000; 45: 351-359.
37. O'Neill SC, Miller L, Hinch R, et al. Interplay between SERCA and sarcolemmal Ca2+ efflux pathways controls spontaneous release of Ca2+ from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol 2004; 559: 121-128.
38. Ammendola A, Geiselhöringer A, Hofmann F, et al. Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta. J Biol Chem 2001; 276: 24153-24159.
39. De Mello WC. Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J Cardiovasc Pharmacol 1998; 32: 75-79.
40. Lochner A, Genade S, Tromp E, et al. Role of cyclic nucleotide phosphodiesterases in ischaemic preconditioning. Mol Cell Biochem 1998; 1861: 169-175.
41. D'Souza S P, Yellon DM, Martin C, et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 2003; 284: H1592-1600.
42. Kim JS, Ohshima S, Pediaditakis P, et al. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004; 39: 1533-1543.
43. Moro MA, Russel RJ, Cellek S, et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 1996; 93: 1480-1485.
44. Heller R, Bussolino F, Ghigo D, et al. Activation of endothelial guanylate cyclase inhibits cellular reactivity. Agents Actions Suppl 1995; 45: 177-181.
45. Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 1996; 78: 780-789.
46. Hempel A, Noll T, Muhs A, et al. Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol Heart Circ Physiol 1996; 270: H1264-H1271.
47. Kubes P. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP. Am J Physiol Heart Circ Physiol 1993; 265: H1909-H1915.
48. Yoshida K, Yoshimura K, Haniuda M. L-arginine inhibits ischemia-reperfusion lung injury in rabbits. J Surg Res 1999; 85: 9-16.
49. Lucas KA, Pitari GM, Kazerounian S, et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414.
50. Pyriochou A, Papapetropoulos A. Soluble guanylyl cyclase: more secrets revealed. Cell Signal 2005; 17: 407-413.
51. Kuhn M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 2003; 93: 700-709.
52. Costa MA, Elesgaray R, Balaszczuk AM, et al. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regul Pept 2006; 135: 63-68.
53. Mount P F, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 2007; 42: 271-279.
54. Braam B, Verhaar MC. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des. 2007; 13: 1727-1740.
55. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 2007; 75: 247-260.
56. Duda T, Goraczniak R, Sharma RK. Distinct inhibitory ATP-regulated modulatory domain (ARMi) in membrane guanylate cyclases. Biochem J 1996; 319: 279-283.
57. Bellamy TC, Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J Biol Chem 2001; 276: 4287-4292.
58. Zwiller J, Revel MO, Malviya AN. Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J Biol Chem 1985; 260: 1350-1353.
59. Kostic TS, Tomi M, Andric SA, et al. Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. J Biol Chem 2002; 277: 16412-16418.
60. Murthy KS. Modulation of soluble guanylate cyclase activity by phosphorylation. Neurochem Int 2004; 45: 845-851.
61. Zabel U, Kleinschnitz C, Oh P, et al. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol 2002; 4: 307-311.
62. Agulló L, Garcia-Dorado D, Escalona N, et al. Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes. Cardiovasc Res 2005; 68: 65-74.
63. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181-190.
64. Huk I, Nanobashvili J, Neumayer C, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischaemia/reperfusion injury in skeletal muscle. Circulation 1997; 96: 667-675.
65. Depré C, Hue L. Cyclic GMP in the perfused heart. Effect of ischaemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett 1994; 345: 241-245.
66. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischaemic heart. Cardiovasc Res 1995; 30: 593-601.
67. Nesher R, Robinson WF, Gibb L, et al. Cyclic nucleotide levels in the perfused rat heart subjected to hypoxia. Experientia 1977; 33: 215-217.
68. Yamaguchi F, Nasa Y, Yabe K, et al. Activation of cardiac muscarinic receptor and ischaemic preconditioning effects in in situ rat heart. Heart Vessels 1997; 12: 74-83.
69. Hoshida S, Yamashita N, Kawahara K, et al. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis. Possible mechanisms. Circulation 1999; 99: 434-440.
70. Padilla F, Garcia-Dorado D, Agulló L, et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 2001; 51: 592-600.
71. Agulló L, Garcia-Dorado D, Escalona N, et al. Effect of ischaemia on soluble and particulate guanylyl cyclasemediated cGMP synthesis in cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 284: 2170-2176.
72. Geisbuhler T P, Schwager TL. Effect of anoxia on cyclic nucleotides and inositol phosphate turnover in cardiac myocytes. J Mol Cell Cardiol 1996; 28: 1857-1866.
73. Agulló L, Garcia-Dorado D, Escalona N, et al. Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells. Am J Physiol Heart Circ Physiol 2002; 283: H917-925.
74. Hempel AM, Friedrich M, Schlüter KD, et al. ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. Am J Physiol 1997; 273: 244-249.
75. Padilla F, Garcia-Dorado D, Agulló L, et al. L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig. Cardiovasc Res 2000; 46: 412-420.
76. Yang XM, Philipp S, Downey JM, et al. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol. 2006; 101: 311-318.
77. Wakui S. Experimental study on myocardial protection by adjunct use of carperitide (hANP) in cardiac surgery. Ann Thorac Cardiovasc Surg 2005; 11: 12-20.
78. du Toit E F, Rossouw E, Salie R, et al. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 2005; 19: 23-31.
79. Maas O, Donat U, Frenzel M, et al. Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG. Br J Pharmacol 2008; 154: 25-31.
80. Hayashi M, Tsutamoto T, Wada A, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol. 2001; 37: 1820-1826.
81. Kitakaze M, Asakura M, Kim J, et al.; J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 2007; 370: 1483-1493.
82. Downey JM, Krieg T, Cohen M V. Mapping preconditioning's signaling pathways: an engineering approach. Ann NY Acad Sci 2008; 1123: 187-196.
83. Krieg T, Qin Q, McIntosh EC, et al. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol 2002; 283: H2322-2330.
84. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004; 286: H468-476.
85. Qin Q, Yang XM, Cui L, et al. Exogenous NO triggers preconditioning via a cGMP- and mitoKATP- dependent mechanism. Am J Physiol Heart Circ Physiol 2004; 287: H712-718.
86. Costa AD, Garlid KD, West IC, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 2005; 97: 329-336.
87. Hausenloy DJ, Tsang A, Mocanu MM, et al. Ischaemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005; 288: H971-976.
88. Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113: 1535-1549.
89. Rodriguez-Sinovas A, Boengler K, Cabestrero A, et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 2006; 99: 93-101.
90. Ruiz-Meana M, Rodríguez-Sinovas A, Cabestrero A, et al. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res 2008; 77: 325-333.
91. Heinzel FR, Luo Y, Li X, et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005; 97: 583-586.
92. Heusch G, Büchert A, Feldhaus S, et al. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006; 101: 354-356.
93. Ruiz-Meana M, Pina P, Garcia-Dorado D, et al. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition. J Physiol 2004; 558: 873-882.
94. Inserte J, Barba I, Hernando V, et al. Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res 2009; 81: 116-122.